jcp conference-coverage

Conference Coverage

American Society of Clinical Oncology 2018 Annual Meeting

06/14/2018

JCP Editors

The American Society of Clinical Oncology (ASCO) is the leading professional organization for physicians and oncology professionals caring for people with cancer. Through its multidisciplinary network of almost...

The...

06/14/2018

Journal of Clinical Pathways

Week in Review: COA Conference Coverage and CAR-T Reimbursement

Conference Coverage

Community Oncology Alliance Annual Conference

04/16/2018

From April 12-13, the Community Oncology Alliance (COA) had its annual conference in National Harbor, Maryland. The conference centered on keeping patients and their needs paramount in transforming the US cancer care...

From...

04/16/2018

Journal of Clinical Pathways

Conference Coverage

NCCN 23rd Annual Conference

03/27/2018

From March 21-23, the National Comprehensive Cancer Network sponsored its Annual Conference in Orlando, Florida. The conference—which focuses on improving the quality, effectiveness, and efficiency of cancer...

From...

03/27/2018

Journal of Clinical Pathways

Conference Coverage

Society of Gynecological Oncology 2018 Annual Meeting on Women`s Cancer

03/26/2018

From March 24-27, the Society of Gynecological Oncology (SGO) hosted its Annual Meeting on Women's Cancer in New Orleans, Louisiana. The meeting brought together gynecologic oncologists from all over the world to...

From...

03/26/2018

Journal of Clinical Pathways

Conference Coverage

ACCC 44th Annual Meeting & Cancer Center Business Summit

03/19/2018

From March 14-16, the Association for Community Cancer Center hosted its Annual Meeting & Cancer Center Business Summit in Washington, DC. The meeting served as the hub of the convergence of business, quality,...

From...

03/19/2018

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology Cancer Survivorship Symposium

03/15/2018

JCP Editors

The American Society of Clinical Oncology (ASCO) featured its Cancer Survivorship Symposium in Orlando, Florida from February 16-17, 2018. The meeting provided information about survivorship issues that both...

The...

03/15/2018

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology Genitourinary Cancers Symposium

03/15/2018

JCP Editors

The 2018 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium provides a forum for physicians and other members of the oncology care and research community who diagnose, treat, and...

The...

03/15/2018

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology Gastrointestinal Cancer Symposium

02/15/2018

JCP Editors

The American Society of Clinical Oncology (ASCO) hosted its annual Gastrointestinal (GI) Cancers Symposium in San Francisco, California, from January 18-20, 2018. The GI Cancers Symposium is a specialized oncology...

The...

02/15/2018

Journal of Clinical Pathways

Conference Coverage

ASCO Cancer Survivorship Symposium

02/14/2018

From February 16-17, the American Society of Clinical Oncology will feature its Cancer Survivorship Symposium in Orlando, Florida. The meeting will provide information about survivorship issues that both oncologists...

From...

02/14/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products